Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease

Cardiovascular Research

Volumn 49, Issue 3, 2001, Pages 543-553

  Van Royen, Niels ^a,b   Piek, Jan J ^b   Buschmann, Ivo ^a   Hoefer, Imo ^a   Voskuil, Michiel ^b   Schaper, Wolfgang ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Arteries; Blood flow; Collateral circulation; Coronary disease; Growth factors

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CELL ADHESION MOLECULE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; HEPARIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ARTERIOLE; ARTERY BLOOD FLOW; CAPILLARY; CELL GROWTH; COLLATERAL CIRCULATION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; MONOCYTE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SHEAR STRESS; SMOOTH MUSCLE FIBER;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSELS; CHEMOKINES; COLLATERAL CIRCULATION; DISEASE MODELS, ANIMAL; DOGS; EXERCISE THERAPY; GENE EXPRESSION; GROWTH SUBSTANCES; MONOCYTES; MORPHOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; RESEARCH DESIGN; STRESS, MECHANICAL; SWINE;

EID: 0035895715     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00206-6     Document Type: Review

References (116)

1. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty
2. Changing outcomes in percutaneous coronary interventions: A study of 34 752 procedures in northern New England, 1990 to 1997
3. Long-term results of RITA-1 trial: Clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised intervention treatment of angina
4. Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction. Israeli Thrombolytic Survey Group
5. Tumor angiogenesis: Therapeutic implications
6. Anti-angiogenesis: New concept for therapy of solid tumors
7. Tumor angiogenesis: A possible control point in tumor growth
8. Mechanisms of angiogenesis
9. 2 homeostasis by hypoxia-inducible factor 1α
10. 2 homeostasis by hypoxia-inducible factor 1
11. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1
12. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
13. The rat and rabbit cornea assay
14. Critical assessment of in vitro and in vivo assays of angiogenesis
15. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
16. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
17. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
18. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
19. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
20. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect
21. Arteriogenesis, the good and bad of it
22. Mechanisms of angiogenesis and arteriogenesis
23. Angiogenesis, arteriogenesis and physiological perfusion: Review of natural history and concepts
24. DNA synthesis and mitoses in coronary collateral vessels of the dog
25. Collateral function in early acute myocardial infarction
26. Prevalence and significance of residual flow to the infarct zone during the acute phase of myocardial infarction
27. Arteriographic predictors of spontaneous improvement in left ventricular function after myocardial infarction
28. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial
29. Adaptive regulation of wall shear stress to flow change in the canine carotid artery
30. Shear stress regulation of artery lumen diameter in experimental atherogenesis
31. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries
32. Basic fibroblast growth factor expression precedes flow-induced arterial enlargement
33. Role of endothelium in responses of vascular smooth muscle
34. Influence of collateral flow on the ischemic tolerance of the heart following acute and subacute coronary occlusion
35. Biomechanical activation: An emerging paradigm in endothelial adhesion biology
36. Hemodynamic forces are complex regulators of endothelial gene expression
37. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium
38. The cis-acting phorbol ester '12-O-tetradecanoylphorbol 13-acetate'-responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression
39. Ultrastructure and molecular histology of rabbit hindlimb collateral artery growth (arteriogenesis)
40. The endothelial surface of growing coronary collateral arteries. Intimal margination and diapedesis of monocytes. A combined SEM and TEM study
41. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb
42. Tumor necrosis factor-α is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine
43. Microvascular and collateral adaptation in swine hearts following progressive coronary artery stenosis
44. Relation of coronary arterial occlusion pressure during percutaneous transluminal coronary angioplasty to presence of collaterals
45. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals
46. Potential protective effect of high coronary wedge pressure on left ventricular function after coronary occlusion
47. Comparison of collateral vascular responses in the donor and recipient coronary artery during transient coronary occlusion assessed by intracoronary blood flow velocity analysis in patients
48. Clin, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion
49. Pharmacological modulation of the human collateral vascular resistance in acute and chronic coronary occlusion assessed by intracoronary blood flow velocity analysis in an angioplasty model
50. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion
51. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/-mice
52. Vasculogenesis
53. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
54. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
55. Endothelial cell precursors are normal components of human umbilical cord blood
56. Isolation of putative progenitor endothelial cells for angiogenesis
57. Evidence for circulating bone marrow-derived endothelial cells
58. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors
59. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion
60. A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro
61. The role of cytokines in monocyte apoptosis
62. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis
63. Role of colony stimulating factors during arteriogenesis (Growth of collateral arteries)
64. Fluid shear stress induces endothelial transforming growth factor β-1 transcription and production. Modulation by potassium channel blockade
65. Shear stress induces transforming growth factor-β 1 release by arterial endothelial cells
66. Fluid shear stress increases transforming growth factor β 1 expression in human osteoblast-like cells: Modulation by cation channel blockades
67. Increased flow and shear stress enhance in vivo transforming growth factor-β 1 after experimental arterial injury
68. In situ localization of transforming growth factor β 1 in porcine heart: Enhanced expression after chronic coronary artery constriction
69. Increased expression of TGF-β 1 in brain tissue after ischemic stroke in humans
70. Transforming growth factor-β is a powerful promotor of arteriogenesis
71. Transforming growth factor type β induces monocyte chemotaxis and growth factor production
72. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes
73. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: A meta-analysis
74. Why is training effective in the treatment of patients with intermittent claudication?
75. Cardiac rehabilitation: Evidence for improvement in myocardial perfusion and function
76. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy
77. Cardiovascular effects of exercise: Role of endothelial shear stress
78. One-year graduated exercise program for men with angina pectoris. Evaluation by physiologic studies and coronary arteriography
79. Exercise and human collateralization: An angiographic and scintigraphic assessment
80. Effect of physical training on treadmill exercise capacity, collateral circulation and progression of coronary disease
81. Investigation of the physiological basis for increased exercise threshold for angina pectoris after physical conditioning
82. Influence of physical exercise on coronary collateral blood flow in chronic experimental two-vessel occlusion
83. Acceleration of coronary collateral development by heparin in conscious dogs
84. Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina
85. Prospective, randomized, placebo-controlled, double-blind, multicenter study of exercise with enoxaparin pretreatment for stable-effort angina
86. Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: A pilot study
87. Exercise training and heparin pretreatment in patients with coronary artery disease
88. Heparin and angiogenic therapy
89. The fibroblast growth factor family: Structural and biological properties
90. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor
91. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation
92. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs
93. Is arteriogenesis inducible when collateral arteries are already recruited
94. Hypothesis: Vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis
95. Immunohistochemical study of intimal microvessels in coronary atherosclerosis
96. Angiogenesis in human coronary atherosclerotic plaques
97. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice
98. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits
99. Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor
100. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines
101. Effect of diabetes mellitus on formation of coronary collateral vessels
102. Adenoviral vectors and gene transfer to the blood vessel wall
103. Analysis of adenoviral transport mechanisms in the vessel wall and optimization of gene transfer using local delivery catheters
104. Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery
105. Microsphere loaded monocytes are potential vectors for therapeutic arteriogenesis
106. Delivery strategies to achieve therapeutic myocardial angiogenesis
107. Quantification of collateral flow in humans: A comparison of angiographic, electrocardiographic and hemodynamic variables
108. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity
109. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty
110. Intracoronary pressure and flow velocity with sensor-tip guidewires: A new methodologic approach for assessment of coronary hemodynamics before and after coronary interventions
111. Detection of coronary collateral flow by a Doppler-tipped guide wire during coronary angioplasty
112. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel® under angiogenetic conditions